Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $331,881 - $384,021
3,300 New
3,300 $367,000
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $137,112 - $163,200
-1,200 Reduced 29.27%
2,900 $356,000
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $500,200 - $595,771
4,100 New
4,100 $530,000
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $259,279 - $321,400
2,000 New
2,000 $311,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.